Effect of human atrial natriuretic peptide for prevention of atrial fibrillation after CABG: a randomised controlled trial
Phase 3
- Conditions
- myocardial infarction, angina
- Registration Number
- JPRN-UMIN000002620
- Lead Sponsor
- ihon University school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 700
Inclusion Criteria
Not provided
Exclusion Criteria
past of arrhythmia cardiogenic shock NYHA class IV congestive heart failure despite treatment sinus bradycardia at rest (<50/min) second -or third-degree AV block clinical hypothyroidism or hyperthyroidism Doctor's decision not to register to this regimen
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of postoperative atrial fibrillation
- Secondary Outcome Measures
Name Time Method 1) age 2) cyclic GMP 3) renin activity, angiotensin-II, aldsterone 4) CK-MB, Tp-I, H-FABP 5) mortality, complication